−455G/A Polymorphism of the β-Fibrinogen Gene is Associated With the Progression of Coronary Atherosclerosis in Symptomatic Men

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Arteriosclerosis, Thrombosis, and Vascular Biology

• Publication date

  1998-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/01.ATV.18.2.265
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Production of C-reactive protein and risk of coronary events in stable and unstable angina. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group.

  1997cited by this paper
• Inflammatory markers as predictors in unstable angina

  1997cited by this paper
• Effects of pravastatin sodium and simvastatin on plasma fibrinogen level and blood rheology in type II hyperlipoproteinemia.

  1996cited by this paper
• The acute rise in plasma fibrinogen concentration with exercise is influenced by the G-453-A polymorphism of the beta-fibrinogen gene.

  1996cited by this paper
• Interindividual and intraindividual variability in plasma fibrinogen, TPA antigen, PAI activity, and CRP in healthy, young volunteers and patients with angina pectoris.

  1996cited by this paper
• Beta fibrinogen gene polymorphisms are associated with plasma fibrinogen and coronary artery disease in patients with myocardial infarction. The ECTIM Study. Etude Cas-Temoins sur l'Infarctus du Myocarde.

  1996cited by this paper
• Hyperlipidemia and coronary disease. Correction of the increased thrombogenic potential with cholesterol reduction.

  1995cited by this paper
• Effects of lipid lowering by pravastatin on progression and regression of coronary artery disease in symptomatic men with normal to moderately elevated serum cholesterol levels. The Regression Growth Evaluation Statin Study (REGRESS).

  1995cited by this paper
• Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group.

  1995cited by this paper
• Fibrinogen and factor VII in the prediction of coronary risk. Results from the PROCAM study in healthy men.

  1994cited by this paper
• Lipoprotein Lp(a) as predictor of myocardial infarction in comparison to fibrinogen, LDL cholesterol and other risk factors: results from the prospective Göttingen Risk Incidence and Prevalence Study (GRIPS)

  1994cited by this paper
• Factor VII and Fibrinogen Levels as Risk Factors for Venous Thrombosis

  1994cited by this paper
• Linkage disequilibrium across the fibrinogen locus as shown by five genetic polymorphisms, G/A −455 (HaeIII), C/T −148 (HindIII/AluI), T/G+1689 (AvaII), and BclI (β‐fibrinogen) and TaqI (α‐fibrinogen), and their detection by PCR

  1994cited by this paper
• The Role of β-Fibrinogen Genotype in Determining Plasma Fibrinogen Levels in Young Survivors of Myocardial Infarction and Healthy Controls from Sweden

  1993cited by this paper
• Genetic variation at the beta-fibrinogen locus in relation to plasma fibrinogen concentrations and risk of myocardial infarction. The ECTIM Study.

  1993cited by this paper
• Human fibrinogen polymorphic site analysis by restriction endonuclease digestion and allele-specific polymerase chain reaction amplification: identification of polymorphisms at positions A alpha 312 and B beta 448.

  1993cited by this paper
• Effect of Three Fibrate Derivatives and of Two HMG-CoA Reductase Inhibitors on Plasma Fibrinogen Level in Patients with Primary Hypercholesterolemia

  1993cited by this paper
• A Six Year Prospective Study of Fibrinogen and Other Risk Factors Associated with Mortality in Stable Claudicants

  1992cited by this paper
• Fibrinogen and Viscosity as Risk Factors for Subsequent Cardiovascular Events in Stroke Survivors

  1992cited by this paper
• Fibrinogen, Viscosity, and White Blood Cell Count Are Major Risk Factors for Ischemic Heart Disease: The Caerphilly and Speedwell Collaborative Heart Disease Studies

  1991cited by this paper
• Effects of fibrinogen and fibrin on the migration of vascular smooth muscle cells in vitro.

  1990cited by this paper
• Acute phase reaction, fibrinogen level and thrombus size.

  1989cited by this paper
• DNA polymorphisms at fibrinogen loci and plasma fibrinogen concentration

  1989cited by this paper
• A Monoclonal Antibody-Based Qunatitative Enzyme Immunoassay for the Determination of Plasma Fibrinogen Concentartions

  1988cited by this paper
• Role of genetic variation at the fibrinogen locus in determination of plasma fibrinogen concentrations.

  1987cited by this paper
• Fibrinogen and risk of cardiovascular disease. The Framingham Study.

  1987cited by this paper
• Fibrinogen, fibrin and fibrin degradation products in relation to atherosclerosis.

  1986cited by this paper
• Blood rheology in arterial disease.

  1986cited by this paper
• Nonuniform recombination within the human beta-globin gene cluster.

  1986cited by this paper
• Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study.

  1986cited by this paper
• [Hyperlipidemia and coronary disease].

  1985cited by this paper
• The platelet fibrinogen receptor.

  1985cited by this paper
• The genes coding for A alpha-, B beta-, and gamma-chains of fibrinogen map to 4q2.

  1984cited by this paper
• Nonuniform recombination within the human beta-globin gene cluster.

  1984cited by this paper
• Effects of fibrin and fibrinogen-degradation products on the growth of rabbit aortic smooth muscle cells in culture.

  1982cited by this paper
• EMBOLISM AND THROMBOSIS OF THE POPLITEAL ARTERY—DIAGNOSIS AND TREATMENT

  1943cited by this paper

• Systemic Low-grade Inflammation and depressive symptomology at chronic phase of ischemic stroke: The Chain Mediating Role of Fibrinogen and Neutrophil counts.

  2021cites this paper
• Pravastatin for lowering lipids.

  2020cites this paper
• Evaluation of single nucleotide polymorphisms in 6 candidate genes and carotid intima-media thickness in community-dwelling residents

  2020cites this paper
• Intraoperative Thrombophilia-Associated Thrombosis of Both Saphenous Veins during Harvesting for Coronary Artery Bypass Grafting

  2020cites this paper
• Polymorphisms -455G/A and -148C/T and Fibrinogen Plasmatic Level as Risk Markers of Coronary Disease and Major Adverse Cardiovascular Events

  2019cites this paper
• Association of genetic variants of hemostatic genes with myocardial infarction in Egyptian patients.

  2018cites this paper
• Pharmacogenetics and Metabolic Disease

  2016cites this paper
• Gene polymorphism and some inflammatory biomarkers associated with coronary artery disease in Egyptian Population

  2015cites this paper
• Wpływ polimorfizmu G455A w genie beta fibrynogenu na stężenie fibrynogenu w zależności od spożycia kwasów tłuszczowych

  2014cites this paper
• Βeta-fibrinogen gene promoter A −455 allele associated with poor longterm survival among 55–71 years old Caucasian women in Finnish stroke cohort

  2014cites this paper
• Impact of -455G/A Polymorphism of the β-Fibrinogen Gene on Platelet Aggregation in Patients With Acute Coronary Syndrome

  2014cites this paper
• The role of coagulation factor XII in fibrin clot formation and fibrinolysis

  2014cites this paper
• Znaczenie czynników genetycznych w chorobie niedokrwiennej serca

  2013cites this paper
• [Determination of molecular genetic markers in acute coronary syndromes and their relationship to cardiovascular adverse events].

  2013cites this paper
• Fibrin(ogen) and thrombotic disease

  2013cites this paper
• Drug Interactions, Pharmacogenomics and Cardiovascular Complication

  2013cites this paper
• Polymorphism in β-fibrinogen and Integrin beta-3 Genes and Risk of Recurrent Spontaneous Miscarriage in Gaza Strip

  2013cites this paper
• A genetic instrument for Mendelian randomization of fibrinogen

  2012cites this paper
• Correlation Between Common Genetic Variants and Risk Factors Associated with Prediction of Cardiovascular Diseases in Dyslipidemic Patients

  2012cites this paper
• Effects of HMG-CoA Reductase Inhibitors on Coagulation and Fibrinolysis Processes

  2012cites this paper
• Association analysis of genetic polymorphisms of factor V, factor VII and fibrinogen β chain genes with human abdominal aortic aneurysm

  2012cites this paper
• Detection of FXIII gene V34L and fibrinogen β-gene - 455G/A polymorphisms among Saudi Arabia population via polymerase chain reaction-reverse hybridization technique

  2012cites this paper
• Fibrinogen gene regulation

  2012cites this paper
• Sequence variations in the FII, FV, F13A1, FGB and PAI-1 genes are associated with differences in myocardial perfusion.

  2011cites this paper
• Novel Insights into Genetics of Arterial Thrombosis

  2011cites this paper
• Platelet polymorphisms: Frequency distribution and association with coronary artery disease in an Indian population

  2011cites this paper
• Effective Lipid-lowering Therapy in High-risk Patients

  2011cites this paper
• Bβ-Fibrinogen Gene Promoter -455 G/A Polymorphism Associates with Severity of Coronary Artery Stenosis in Male Victims of Sudden Pre- Hospital Death

  2011cites this paper
• Statistical Applications in Genetics and Molecular Biology A Multiple Testing Approach to High-Dimensional Association Studies with an Application to the Detection of Associations between Risk Factors of Heart Disease and Genetic Polymorphisms

  2011influential citation
• Role of Genetic Changes in the Progression of Cardiovascular Diseases

  2011cites this paper
• The Genetics of Thrombosis

  2010cites this paper
• The association of beta-fibrinogen 455 G/A gene polymorphism with left atrial thrombus and severe spontaneous echo contrast in atrial fibrillation.

  2010cites this paper
• Atriyal fibrilasyonda beta-fibrinojen 455 G/A gen polimorfizmi ile sol atriyal trombüs ve ciddi spontan eko-kontrast arasindaki ilişki

  2010cites this paper
• Advanced age, low left atrial appendage velocity, and Factor V promoter sequence variation as predictors of left atrial thrombosis in patients with nonvalvular atrial fibrillation

  2010cites this paper
• SNPs: Single Nucleotide Polymorphisms and Pharmacogenomics: Individually Designed Drug Therapy

  2010cites this paper
• Prevalence of the fibrinogen β‐chain, angiotensin‐converting enzyme and plasminogen activator inhibitor‐1 polymorphisms in Costa Rican young adults with thrombotic disease

  2010cites this paper
• Antithrombotic drug therapy in cardiovascular disease

  2010cites this paper
• G-455A polymorphism of beta-fibrinogen gene and the risk of premature myocardial infarction in Greece.

  2010cites this paper
• El fibrinógeno como factor de riesgo de enfermedad aterotrombótica

  2009cites this paper
• Is plasma fibrinogen useful in evaluating ischemic stroke patients?: why, how, and when.

  2009cites this paper
• The Functional Effects of the −455G/A Polymorphism on the IL-6-Induced Expression of the β-fibrinogen Gene may be due to Linkage Disequilibrium with Other Functional Polymorphisms

  2009cites this paper
• Untersuchung der Assoziation von Einzelnukleotidpolymorphismen im Fibrinogen-α- und β-Gen mit dem Myokardinfarkt

  2009influential citation
• Genetic variation in fibrinogen; its relationship to fibrinogen levels and the risk of myocardial infarction and ischemic stroke

  2009cites this paper
• The Functional Effects of the -455G/A Polymorphism on the IL-6-Induced Expression of the b-Fibrinogen Gene may be due to Linkage Disequilibrium with Other

  2009cites this paper
• Carrier-state of the A allele of – 455G>A polymorphism within the beta fibrinogen gene increases the risk of coronary artery disease in the presence of elevated concentration of serum triacylglycerols

  2009cites this paper
• Prothrombotic genetic variants and atherosclerosis in patients with cerebral ischemia of arterial origin.

  2009cites this paper
• Fibrinogen Genes and Myocardial Infarction: A Haplotype Analysis

  2008cites this paper
• Pharmacogenomics in acute coronary syndrome

  2008cites this paper
• Frequency distribution of the G/A alleles of the β-fibrinogen gene in the Lebanese population

  2008cites this paper
• Genetica van atherotrombose

  2008cites this paper
• Genetic factors in drug metabolism.

  2008cites this paper
• Associations between common fibrinogen gene polymorphisms and cardiovascular disease in older adults

  2008cites this paper
• Plasma fibrinogen γ′ chain content in the thrombotic microangiopathy syndrome

  2007cites this paper
• The fibrinogen -148 C/T polymorphism influences inflammatory response in experimental endotoxemia in vivo.

  2007cites this paper
• Thrombophilia: Clinical and Laboratory Assessment and Management

  2007cites this paper
• CHAPTER 8 – Molecular Basis of Lipoprotein Disorders, Atherogenesis, and Thrombosis

  2007cites this paper
• Increase of Plasma Fibrinogen Levels and Variability with Age in a Sample of Middle Aged Healthy Men

  2007cites this paper
• Recent development in pharmacogenomics: from candidate genes to genome-wide association studies

  2007cites this paper
• Analysis of the effect of multiple genetic variants of cardiovascular disease risk on insulin concentration variability in healthy adults of the STANISLAS cohort. The role of FGB-455 G/A polymorphism.

  2007cites this paper
• Fibrinógeno: ¿Factor o indicador de riesgo cardiovascular?

  2006cites this paper
• Clinical implications of pharmacogenomics of statin treatment

  2006cites this paper
• Should neurologists measure fibrinogen concentrations?

  2006cites this paper
• Pharmacogenomics of cholesterol-lowering therapy.

  2006cites this paper
• Present status of outcome prediction of invasive coronary treatment by using genetic markers

  2006cites this paper
• Molecular Pathogenesis of Cardiovascular Disease

  2006cites this paper
• Genetic polymorphisms in coagulation and fibrinolysis systems versus thromboembolic risk of estrogen-progestin therapies in women

  2005cites this paper
• Trombosis arterial y polimorfismos genéticos: demasiados actores, escenario complejo

  2005cites this paper
• Die Bedeutung des genetischen Polymorphismus im Gerinnungssystem und in der Akut-Phase-Reaktion bei Patienten mit ischämischem Schlaganfall

  2005cites this paper
• Fibrinógeno. Vieja proteína hemostática con nueva función: marcador no invasivo de aterosclerosis subclínica

  2005cites this paper
• Le fibrinogène a-t-il une place pour évaluer le risque d’accident cardiovasculaire ischémique ?

  2005cites this paper
• A Hepatocyte Nuclear Factor-3 Site in the Fibrinogen β Promoter Is Important for Interleukin 6-induced Expression, and Its Activity Is Influenced by the Adjacent –148C/T Polymorphism*

  2005cites this paper
• Genetic variation in the rate-limiting enzyme in cholesterol catabolism (cholesterol 7alpha-hydroxylase) influences the progression of atherosclerosis and risk of new clinical events.

  2005cites this paper
• Fibrinogen and other coronary risk factors.

  2005cites this paper
• Pharmacogenomics and cardiovascular drugs: need for integrated biological system with phenotypes and proteomic markers.

  2005cites this paper
• DEVELOPMENT AND APPLICATION OF AN INDIVIDUALISED GENETIC APPROACH FOR CARDIOVASCULAR DISEASE RISK REDUCTION

  2005cites this paper
• A Genome Search for Genetic Determinants That Influence Plasma Fibrinogen Levels

  2005cites this paper
• Association between Thr312Ala Polymorphism in α −Fibrinogen Gene and Coronary Artery Disease*

  2005cites this paper
• Genetic Polymorphisms and Response to HMG-CoA Reductase Inhibitors

  2005cites this paper
• SNPs and NPs 1 THE RELATIONSHIP OF SINGLE NUCLEOTIDE POLYMORPHISMS AND INFLAMMATORY MARKERS OF CORONARY ARTERY DISEASE : SIGNIFICANCE FOR NURSE PRACTITIONERS IN AN ACUTE CARE SETTING by

  2005influential citation
• Thrombotic Vascular Disease

  2005cites this paper
• Association between Thr 312 Ala Polymorphism in α − Fibrinogen Gene and Coronary Artery Disease *

  2005cites this paper
• HMG-CoA reductase inhibitor pharmacogenomics: overview and implications for practice.

  2005cites this paper
• Cardiovascular pharmacogenomics

  2005cites this paper
• Beta-fibrinogen haplotypes and the risk for cardiovascular disease in a dialysis cohort.

  2005cites this paper
• Pharmacogenetics of lipid diseases

  2004cites this paper
• Pharmacogenetics of HMG-CoA reductase inhibitors: exploring the potential for genotype-based individualization of coronary heart disease management.

  2004cites this paper
• Role of pharmacogenomics in drug development

  2004cites this paper
• Association of Polymorphic Marker G(−455)A of Gene FGB with Coronary Artery Disease

  2004cites this paper
• Genetic Determinants of Arterial Thrombosis

  2004cites this paper
• Genetic and Environmental Determinants of Fibrin Structure and Function: Relevance to Clinical Disease

  2004cites this paper
• Associação entre o efeito de contraste espontâneo na aorta torácica e eventos isquêmicos encefálicos recentes. Estudo através do ecocardiograma transesofágico

  2004cites this paper
• Genetically defined hyperlipidemia.

  2004cites this paper
• Genetics of thrombophilia: impact on atherogenesis

  2004cites this paper
• Genetic Polymorphisms in Emerging Cardiovascular Risk Factors and Response to Statin Therapy

  2004cites this paper
• Plasma fibrinogen concentration predicts the risk of myocardial infarction differently in various parts of Europe: effects of β-fibrinogen genotype and environmental factors

  2004cites this paper
• Fibrinogen Gene Promoter −455 A Allele as a Risk Factor for Lacunar Stroke

  2003cites this paper
• European guidelines on cardiovascular disease prevention in clinical practice; Third Joint Task Force of European and other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of eight societies and by invited experts)

  2003cites this paper
• Relationship of the platelet glycoprotein PlA and fibrinogen T/G+1689 polymorphisms with peripheral arterial disease and ischaemic heart disease.

  2003cites this paper
• Association of increased levels of fibrinogen and the -455G/A fibrinogen gene polymorphism with chronic periodontitis.

  2003cites this paper
• The genetics of atherothrombotic disorders: a clinician's view

  2003cites this paper